Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-12, Stock:LLY, The news for the past five days is as follows:
2018-06-05: NEWS1: Health Care Sector Update for 06/05/2018: MYL,VKTX,PLX,LLY.NEWS2: Health Care Sector Update for 06/05/2018: MYL,VKTX,PLX,LLY.NEWS3: Lilly Recommends Shareholders Reject Below-Market Mini-Tender Offer by TRC Capital Corp..NEWS4: Health Care Sector Update for 06/05/2018: VKTX,PLX,LLY.NEWS5: Health Care Sector Update for 06/05/2018: VKTX,PLX,LLY.NEWS6: Merck Presents Positive Melanoma Data on Keytruda at ASCO.NEWS7: Merck Presents Positive Melanoma Data on Keytruda at ASCO.NEWS8: DDW 2018: Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial.NEWS9: Health Care Sector Update for 06/05/2018: PLX, VKTX, LLY.NEWS10: Health Care Sector Update for 06/05/2018: PLX, VKTX, LLY.NEWS11: FDA Expands Lilly's ALIMTA® (pemetrexed) Label to Include Combination with KEYTRUDA® (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression.NEWS12: Eli Lilly: FDA Expands ALIMTA Label To Include Combination With KEYTRUD.NEWS13: Eli Lilly: FDA Expands ALIMTA Label To Include Combination With KEYTRUD.
2018-06-06: NEWS1: How Did Eli Lilly Perform in May?.NEWS2: Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive.NEWS3: Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive.NEWS4: Major M&A Deals in Pharmaceutical Sector in May and June.
2018-06-07: NEWS1: Eli Lilly CEO Calls For Uniform Prices, Better Use Of Technology In Health Care.NEWS2: J&J Receives Buyout Offer for Sterilization Products Unit.NEWS3: J&J Receives Buyout Offer for Sterilization Products Unit.NEWS4: Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus.NEWS5: Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus.NEWS6: J&J Receives Buyout Offer for Sterilization Products Unit.
2018-06-08: NEWS1: Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant.NEWS2: Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant.NEWS3: Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant.NEWS4: Stocks making the biggest moves premarket: VZ, AAPL, SFIX, PM, FB & more.NEWS5: Stocks making the biggest moves premarket: VZ, AAPL, SFIX, PM, FB & more.
2018-06-11: NEWS1: Cramer Remix: What Trump’s endgame with China could really be about.NEWS2: Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't.NEWS3: Cramer: Eli Lilly's share price recovery symbolizes this ....NEWS4: Market attitude seen in Eli Lilly's share price recovery.NEWS5: Cramer: Eli Lilly's share price recovery symbolizes this market's attitude.NEWS6: AstraZeneca's Tagrisso Wins EU Nod for First-Line Lung Cancer.NEWS7: AstraZeneca's Tagrisso Wins EU Nod for First-Line Lung Cancer.NEWS8: JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space.NEWS9: JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space.NEWS10: Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe.NEWS11: Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe.NEWS12: Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval.NEWS13: Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval.NEWS14: The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie.NEWS15: The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie.NEWS16: AstraZeneca&apos;s Tagrisso Wins EU Nod for First-Line Lung Cancer.NEWS17: Abbvie/Roche&apos;s Leukemia Drugs Combination Gets FDA Approval.NEWS18: JAK Inhibitors&apos; Prospects Strong: 4 Stocks Ruling the Space.NEWS19: The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie.NEWS20: Elanco Animal Health Introduces New Respiratory PRRS Vaccine.NEWS21: Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology.NEWS22: Eli Lilly To Present New Data From Its Immunology Portfolio - Quick Facts.NEWS23: Eli Lilly To Present New Data From Its Immunology Portfolio - Quick Facts.

Answer: Decrease